Reports of a new, potentially concerning Covid-19 variant, B.1.1.529, are creating greater uncertainty as we enter winter. Pseudovirus studies of the variant, which has 32 spike mutations, are expected to classify it as vaccine-evading within the next few days.
Little evidence has yet emerged that the variant has spread beyond South Africa. However, we already raised concerns on Monday about a potential new variant in Europe. This is because of the uncharacteristically high spread of infections in the EU, despite relatively high vaccine immunity in many countries.
This article is only available to Macro Hive subscribers. Sign-up to receive world-class macro analysis with a daily curated newsletter, podcast, original content from award-winning researchers, cross market strategy, equity insights, trade ideas, crypto flow frameworks, academic paper summaries, explanation and analysis of market-moving events, community investor chat room, and more.
